Cecile Nguyen, MD
Geriatric Medicine · East Point, GANPI 1609819283
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.2% of the total across 122 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by Lilly USA, LLC at 25.4% of the total. Reporting peaked in 2021 at $683 and has fallen 82.9% since, to $117 in 2025.
Across 122 payments — averaging $19.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$611
- AstraZeneca$275
- Novo Nordisk$273
- AbbVie$173
- Boehringer Ingelheim$169
- Pfizer$149
- plus $758 from 11 others
What the payments were for
- Food & beverage$2,31696%
- Education$331%
- Gifts$592%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 33 | $611 |
| AstraZeneca | 10 | $275 |
| Novo Nordisk | 19 | $273 |
| AbbVie(2 entities) | 11 | $173 |
| Boehringer Ingelheim | 9 | $169 |
| Pfizer | 7 | $149 |
| Vertos Medical, Inc. | 1 | $143 |
| Sanofi-aventis U.S. LLC | 8 | $128 |
| Biogen | 7 | $123 |
| Bayer | 6 | $111 |
| Mannkind Corporation | 1 | $59 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $53 |
| Otsuka America Pharmaceutical, Inc. | 3 | $52 |
| Corcept Therapeutics | 1 | $31 |
| Johnson & Johnson | 1 | $22 |
| Shire North American Group Inc | 1 | $22 |
| Dexcom, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- mild Device Kit$143
- FARXIGA$123
How this compares
$2,408 in reported general payments places this provider in the 80th percentile of 75 geriatric medicine providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 82 | $99,853 |
| FarxigaDapagliflozin Propanediol | 84 | $82,890 |
| JardianceEmpagliflozin | 63 | $68,659 |
| OzempicSemaglutide | 35 | $64,659 |
| EliquisApixaban | 39 | $31,183 |
| TrintellixVortioxetine Hydrobromide | 15 | $18,623 |
| KerendiaFinerenone | 19 | $17,327 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 14 | $14,971 |
| SynthroidLevothyroxine Sodium | 72 | $6,325 |
| Levothyroxine Sodium | 246 | $2,174 |
| Pantoprazole Sodium | 194 | $2,001 |
| Duloxetine Hcl | 59 | $1,877 |
| Gabapentin | 131 | $1,688 |
| Memantine Hcl | 79 | $1,592 |
| Nifedipine ErNifedipine | 68 | $1,586 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $611 | $99,85382 claims |
| AstraZenecaFarxiga | $275 | $82,89084 claims |
| Boehringer IngelheimJardiance | $169 | $68,65963 claims |
| Novo NordiskOzempic | $273 | $64,65935 claims |
| PfizerEliquis | $149 | $31,18339 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $53 | $18,62315 claims |
| BayerKerendia | $111 | $17,32719 claims |
| AbbVieSynthroid | $173 | $6,32572 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 75 geriatric medicine providers in Georgia.
Other geriatric medicine in East Point
- Joseph MiccaMarietta$130K
- Monica ParkerAtlanta$74K
- Daniel DinoSt Marys$13K
- Wayne MorrisAthens$12K
- Harry StrothersMacon$10K
- Scott MikellStatesboro$10K
- Theodore JohnsonAtlanta$6K
- Anitha KoduruEvans$6K
- Sudeshna NandiDuluth$6K
- Jayesh PatelMacon$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.